AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Gross Profit
AxoGen Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Gross Profit
$128.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
30%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is AxoGen Inc's Gross Profit?
Gross Profit
128.3m
USD
Based on the financial report for Mar 31, 2024, AxoGen Inc's Gross Profit amounts to 128.3m USD.
What is AxoGen Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
30%
Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for AxoGen Inc have been 11% over the past three years , 12% over the past five years , and 30% over the past ten years .